Lumen Subject vaccination web site prepares for teenagers ages 12 to 15 – KIRO 7 Information Seattle

SEATTLE – The Food and Drug Administration has extended Pfizer-BioNTech’s emergency approval for the COVID-19 vaccine to children ages 12-15, but has yet another hurdle to overcome.

Soon it will be the turn of children outside the mass vaccination site at the Lumen Field Event Center.

In anticipation of their arrival, pediatricians are working with the city to prepare the room.

Swedish hospital staff said the focus is on eliminating problems from the process. One idea is to create pods or private areas where people under the age of 16 can learn about vaccines with their parents.

Clinical studies show the Pfizer vaccine is 100% effective in preventing COVID-19 in children ages 12-15.

The Centers for Disease Control and Prevention’s vaccine advisory board will meet on Wednesday to review the vaccine. If approved, 17 million children and teenagers will have access to the vaccine this week.

“The response to the vaccine was excellent and even better in the younger age group than in the 16-25 age group,” said Dr. Peter Marks from the Food and Drug Administration’s Center for Biologics Evaluation and Research.

However, a recent study showed that many parents need to be convinced to immunize their children.

While nearly a third said they would get their children vaccinated as soon as possible, nearly half said they would either wait and see how well the vaccine works or stick to it if schools asked.

A quarter of respondents said they will not have their children vaccinated.

Meanwhile, the demand for vaccinations at Lumen Field has slowed. Appointments are no longer required.

The location can accommodate up to 200 people in one hour.